MOLECULAR BIOLOGY OF HUMAN ERYTHROCYTE ALPHA-SPECTRIN
人红细胞 α-血影蛋白的分子生物学
基本信息
- 批准号:6390847
- 负责人:
- 金额:$ 32.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-15 至 2004-08-31
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting bone marrow transplantation congenital hemolytic anemia disease /disorder model erythrocyte membrane erythroleukemia gel mobility shift assay gene expression gene mutation genetic promoter element genetically modified animals hematopoietic stem cells hereditary spherocytosis human tissue laboratory mouse membrane proteins molecular biology molecular dynamics polymerase chain reaction protein structure function single strand conformation polymorphism site directed mutagenesis spectrin tissue /cell culture transfection /expression vector
项目摘要
DESCRIPTION: (Investigator's abstract) The long-term goals of this proposal are
to elucidate the molecular mechanisms involved in normal and abnormal
expression of the erythrocyte membrane protein a-spectrin. Erythrocyte
a-spectrin is an important component of the erythrocyte membrane skeleton. The
first aim of this proposal is to identify a-spectrin mutations in patients with
recessively inherited hereditary spherocytosis and hereditary
pyropoikilocytosis, severe hemolytic anemias, and to analyze the structural
and/or functional significance of these abnormalities. The second aim of this
proposal is to identify and characterize the promoter and other key regulatory
factors that control expression of the erythrocyte a spectrin gene. These
results will be applied to the study of the role of a-spectrin gene
transcription in erythropoiesis and membrane biogenesis and to the genetic
study of patients with hemolytic anemia who have been found to have mutations
in the putative a-spectrin gene promoter. The third aim of this proposal is to
correct the defect in an a spectrin deficient murine erythroleukemia cell line
and in the erythroid cells of sph/sph mice, an a-spectrin deficieny model of
inherited hemolytic anemia, via retroviral transduction of the a-spectrin cDNA.
The general methodology tc be utilized in this research includes: study of
genomic DNA from patients with a-spectrin linked rHS and HPP using PCR-based
single stranded conformational polymorphism (SSCP) analysis, followed by
nucleotide sequence analysis cloning and structural analysis of the cDNA and
genomic fragments of the a-spectrin gene relevant to its expression and
regulation by the use of recombinant DNA technology; study of cis-acting
sequences by gene manipulation followed b, gene transfer/expression studies in
tissue culture cells; studies of trans-acting factors by electrophoretic
mobility shift assays, DNAse-I footprinting, methylation interference
techniques and site-directed mutagenesis followed by in vitrc and in vivo
analyses, and guanine-adenine ligation-mediated PCR (GA-LMPCR) dimethyl sulfate
in vivo footprinting developmental and tissue-specific studies of the
regulatory sequences of the a-spectrin gene promoter in transgenic mice; In
vitro transduction of a-spectrin deficient MEL cells with a retrovirus
containing the a-spectrin cDNA transduction of hematopoietic stem cells (HSCs)
from a-spectrin deficient sph/sph mice with an ecotropic retrovirus containing
the a-spectrin cDNA, followed by HSC-retroviral gene transplant into the
sph/sph mice. These studies will provide important insights into our studies of
the role of a-spectrin in normal and disease states.
描述:(研究者摘要)本提案的长期目标是
以阐明正常和异常的
红细胞膜蛋白α-血影蛋白的表达。红细胞
α-血影蛋白是红细胞膜骨架的重要组分。的
该建议的第一个目的是鉴定患有以下疾病的患者中的α-血影蛋白突变:
遗传性球形红细胞增多症和遗传性
热变红细胞症,严重的溶血性贫血,并分析结构
和/或这些异常的功能意义。第二个目的是
建议是确定和表征启动子和其他关键调控
控制红细胞血影蛋白基因表达的因子。这些
结果将应用于α-血影蛋白基因的作用研究
转录在红细胞生成和膜生物发生中的作用,
对已发现有突变的溶血性贫血患者的研究
在假定的α-血影蛋白基因启动子中。本建议的第三个目的是
纠正α血影蛋白缺陷鼠红白血病细胞系中的缺陷
在sph/sph小鼠的红系细胞中,
遗传性溶血性贫血,通过逆转录病毒转导的α-血影蛋白cDNA。
本研究所采用的一般方法包括:
使用基于PCR的方法从患有α-血影蛋白连接的rHS和HPP的患者的基因组DNA
单链构象多态性(SSCP)分析,然后
cDNA的核苷酸序列分析、克隆和结构分析,
与其表达相关的α-血影蛋白基因的基因组片段,
利用重组DNA技术调控;顺式作用的研究
序列通过基因操作,然后B,基因转移/表达研究
组织培养细胞.电泳法研究反式作用因子
迁移率变动分析,DNAse-I足迹法,甲基化干扰
技术和定点诱变,然后在体外和体内
鸟嘌呤-腺嘌呤连接介导的PCR(GA-LMPCR)硫酸二甲酯
体内足迹发育和组织特异性研究
转基因小鼠中α-血影蛋白基因启动子的调控序列;
用逆转录病毒体外转导α-血影蛋白缺陷MEL细胞
含有α-血影蛋白cDNA转导的造血干细胞(HSC)
来自a-血影蛋白缺陷型sph/sph小鼠,使用包含以下物质的亲嗜性逆转录病毒
a-血影蛋白cDNA,随后将HSC-逆转录病毒基因移植到
sph/sph小鼠。这些研究将为我们研究
α-血影蛋白在正常和疾病状态中的作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PATRICK G GALLAGHER其他文献
PATRICK G GALLAGHER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PATRICK G GALLAGHER', 18)}}的其他基金
Novel Mechanisms of Congenital Dyserythropoietic Anemia
先天性红细胞生成不良性贫血的新机制
- 批准号:
10454333 - 财政年份:2020
- 资助金额:
$ 32.7万 - 项目类别:
Novel Mechanisms of Congenital Dyserythropoietic Anemia
先天性红细胞生成不良性贫血的新机制
- 批准号:
9887377 - 财政年份:2020
- 资助金额:
$ 32.7万 - 项目类别:
Novel Mechanisms of Congenital Dyserythropoietic Anemia
先天性红细胞生成不良性贫血的新机制
- 批准号:
10192709 - 财政年份:2020
- 资助金额:
$ 32.7万 - 项目类别:
Nonenzymatic Gene Editing in Treatment of Heredity Spherocytosis
非酶基因编辑治疗遗传性球形红细胞增多症
- 批准号:
10305603 - 财政年份:2019
- 资助金额:
$ 32.7万 - 项目类别:
Coordinated regulation of vascular smooth muscle phenotype by p300, CBP, and TET2
p300、CBP 和 TET2 对血管平滑肌表型的协调调节
- 批准号:
10308706 - 财政年份:2018
- 资助金额:
$ 32.7万 - 项目类别:
Responsiveness and non-responsiveness to transfused RBCs in mice and humans.
小鼠和人类对输注红细胞的反应性和无反应性。
- 批准号:
9918440 - 财政年份:2017
- 资助金额:
$ 32.7万 - 项目类别:
Yale Cooperative Center of Excellence in Hematology
耶鲁大学血液学卓越合作中心
- 批准号:
10454355 - 财政年份:2015
- 资助金额:
$ 32.7万 - 项目类别:
Yale Cooperative Hematology Specialized Core Center
耶鲁大学合作血液学专业核心中心
- 批准号:
9987207 - 财政年份:2015
- 资助金额:
$ 32.7万 - 项目类别:
Yale Cooperative Center of Excellence in Hematology
耶鲁大学血液学卓越合作中心
- 批准号:
10249339 - 财政年份:2015
- 资助金额:
$ 32.7万 - 项目类别:
Yale Cooperative Hematology Specialized Core Center
耶鲁大学合作血液学专业核心中心
- 批准号:
8972977 - 财政年份:2015
- 资助金额:
$ 32.7万 - 项目类别:
相似海外基金
Prevention of age-related hearing loss using bone marrow transplantation
利用骨髓移植预防与年龄相关的听力损失
- 批准号:
23K08999 - 财政年份:2023
- 资助金额:
$ 32.7万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Tuning tyrosine kinase signalling to improve haematopoietic stem cell expansion and bone marrow transplantation
调节酪氨酸激酶信号传导以改善造血干细胞扩增和骨髓移植
- 批准号:
2889841 - 财政年份:2023
- 资助金额:
$ 32.7万 - 项目类别:
Studentship
A Novel Bone Marrow Transplantation Approach for Sickle Cell Disease Using Targeted Marrow Irradiation
使用靶向骨髓照射治疗镰状细胞病的新型骨髓移植方法
- 批准号:
10737358 - 财政年份:2023
- 资助金额:
$ 32.7万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10722602 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
一项针对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者进行非亲缘供体骨髓移植与免疫抑制治疗比较的 III 期随机试验
- 批准号:
10368246 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10600143 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
1/2A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia
1/2A III 期随机试验,比较无关供体骨髓移植与免疫抑制治疗对新诊断患有严重再生障碍性贫血的儿童和年轻成人患者的影响
- 批准号:
10370775 - 财政年份:2022
- 资助金额:
$ 32.7万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10303678 - 财政年份:2021
- 资助金额:
$ 32.7万 - 项目类别:
The mycobiota, bone marrow transplantation, and clinical outcomes
真菌群、骨髓移植和临床结果
- 批准号:
10415200 - 财政年份:2021
- 资助金额:
$ 32.7万 - 项目类别: